Back to search

Netherlands· NL-e96bb2d9e9c3

Ixiaro, suspensie voor injectie

A encephalitis, japanische, inaktiviert, ganzes virus product containing geïnactiveerd japanse encephalitis virusvaccin, stam sa14-14-2, registered in Netherlands by Intercell Austria AG. The same ATC class is registered in 11 of our 19 countries.

ATC J07BA02

Checked against CBG-MEB (Netherlands) on

Informational only — not a medical device.

SOURCE REGISTER · NLCBG-MEB (Netherlands)normalisedIxiaro, suspensie voor injectieATCJ07BA02REGISTER NO.NL-e96bb2d9e9c3PACKS LISTED1CHECKEDSeptember 29, 2026

Where it is registered

Encephalitis, japanische, inaktiviert, ganzes virus is registered in 11 of 19 countries.

Countries holding a registration under ATC J07BA02 (encephalitis, japanische, inaktiviert, ganzes virus), each read from that country’s own register.

  • This record: Netherlands, from CBG-MEB (Netherlands)
  • 7 of them publish a price we can compare per daily dose

Encephalitis, japanische, inaktiviert, ganzes virus · ATC J07BA02

11 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Ireland
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

CBG-MEB (Netherlands)
Active substance
GEÏNACTIVEERD JAPANSE ENCEPHALITIS VIRUSVACCIN, stam SA14-14-2
Manufacturer
Intercell Austria AG
Country
Netherlands (NL)
ATC code
J07BA02
ATC class
Encephalitis, japanische, inaktiviert, ganzes Virus
Reimbursed
Not published by this register
Source register
CBG-MEB (Netherlands)
Last checked
September 29, 2026

Packs & prices · 1

  • cbg_meb_id
    EU/1/08/501

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/bf71cf9a-4368-4ab9-be71-d764c97ebbf4
GET /v1/drugs/bf71cf9a-4368-4ab9-be71-d764c97ebbf4?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Suspensie voor injectie",
  "route": "Intramusculair gebruik",
  "soort": null,
  "source": "cbg_meb",
  "smpc_url": "https://www.ema.europa.eu/en/documents/product-information/ixiaro-epar-product-information_nl.pdf",
  "strength": null,
  "atc_label": "Encephalitis, Japanese, Inactivated, Whole Virus",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/cp101840",
  "excipients": [
    "ALUMINIUMHYDROXIDE, GEHYDRATEERD, VOOR ADSORPTIE",
    "DINATRIUMWATERSTOFFOSFAAT 0-WATER (E 339)",
    "KALIUMDIWATERSTOFFOSFAAT 0-WATER (E 340)",
    "NATRIUMCHLORIDE",
    "WATER VOOR INJECTIE"
  ],
  "substances": [
    "GEÏNACTIVEERD JAPANSE ENCEPHALITIS VIRUSVACCIN, stam SA14-14-2"
  ],
  "leaflet_url": null,
  "authorised_at": "2009/03/31",
  "procedure_number": "EMEA/H/C/000963",
  "dispensing_status": "Uitsluitend recept",
  "registration_number": "EU/1/08/501",
  "additional_monitoring": "N"
}

See everything about encephalitis, japanische, inaktiviert, ganzes virus.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.